ASX:PKYSoftware & ServicesApplication Software
Pathkey.AI Ltd
$0.031
$0.003 (8.82%)
Day Range
$0.030 – $0.034
52 Week Range
$0.013 – $0.075
Volume
2.32M
Avg Volume (10D)
3.76M
Market Cap
$38.53M
Price Chart
Market Statistics
Open$0.034
Previous Close$0.034
Day High$0.034
Day Low$0.030
52 Week High$0.075
52 Week Low$0.013
Valuation
Market Cap38.53M
Shares Outstanding1.24B
Price to Book22.95
Trading Activity
Volume2.32M
Value Traded72.93K
Bid$0.031 × 134,532
Ask$0.035 × 332,379
Performance
1 Day3.03%
5 Day13.33%
13 Week-30.61%
52 Week90.13%
YTD112.50%
Technical Indicators
RSI (14)38.60
50-Day SMA$0.046
200-Day SMA$0.030
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]